Search results for: 'biological solutions'

This study provides an outlook of the mobility solutions and business models available or emerging in the key Asian countries of Japan, South Korea, and Singapore. These countries have implemented multiple mobility solutions for their economically developed and densely populated large cities. This study researches and analyzes the trends in these c...

10 Jan 2018  |  Asia Pacific  |  Market Research

APAC Biosimilar Market, Forecast 2025

Patent Expiries, Defined Regulatory Pathways, and Escalating Healthcare Costs to Boost Growth

Infographics

×

Key Issues Addressed Key Benefits

Biosimilars is a massive opportunity; regardless of a slow start, the market will eventually be a huge business. As per Frost & Sullivan’s estimate, biologic drugs worth $70–$80 billion will lose exclusivity in the next 5 years globally and APAC’s contribution would be more than 20%. Countries in the region, such as India, China, and South Korea, o...

06 Jul 2017  |  Asia Pacific  |  Market Research

Growth Opportunities in APAC Oncology Diagnostics Market, Forecast to 2021

Innovation, Technology Integration, and New Customer Segments to Drive New Business Growth

Infographics

×

There is high growth in the Asia-Pacific (APAC) oncology diagnostics market due to increasing incidence of cancer and the drastic reduction in incidence age owing to a plethora of reasons in the regional market. The major drivers for the APAC cancer diagnostics market are increase in adoption of technology platforms, access to targeted cancer thera...

Innovations in logistics are aplenty with APAC fueling a lot of this activity from its home ground. From self-running trucks to automated contracts, the supply chain is ripe for innovation and homegrown APAC start-ups are plowing the way. The market is seeing the rise of these new breed of participants along key future themes, including artificial ...